Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications

Neurosci Bull. 2021 Jun;37(6):863-880. doi: 10.1007/s12264-021-00638-3. Epub 2021 Feb 13.

Abstract

Major depressive disorder (MDD), also referred to as depression, is one of the most common psychiatric disorders with a high economic burden. The etiology of depression is still not clear, but it is generally believed that MDD is a multifactorial disease caused by the interaction of social, psychological, and biological aspects. Therefore, there is no exact pathological theory that can independently explain its pathogenesis, involving genetics, neurobiology, and neuroimaging. At present, there are many treatment measures for patients with depression, including drug therapy, psychotherapy, and neuromodulation technology. In recent years, great progress has been made in the development of new antidepressants, some of which have been applied in the clinic. This article mainly reviews the research progress, pathogenesis, and treatment of MDD.

Keywords: Major depressive disorder; Pathogenesis; Progress; Treatment.

Publication types

  • Review

MeSH terms

  • Antidepressive Agents / therapeutic use
  • Depressive Disorder, Major* / drug therapy
  • Humans
  • Neuroimaging
  • Proteomics

Substances

  • Antidepressive Agents